15.67
price up icon1.36%   0.21
after-market アフターアワーズ: 15.86 0.19 +1.21%
loading
前日終値:
$15.46
開ける:
$15.37
24時間の取引高:
2.08M
Relative Volume:
1.44
時価総額:
$2.73B
収益:
-
当期純損益:
$-382.71M
株価収益率:
-5.9809
EPS:
-2.62
ネットキャッシュフロー:
$-325.64M
1週間 パフォーマンス:
+1.75%
1か月 パフォーマンス:
+5.24%
6か月 パフォーマンス:
-13.85%
1年 パフォーマンス:
-44.86%
1日の値動き範囲:
Value
$15.22
$16.10
1週間の範囲:
Value
$14.58
$16.10
52週間の値動き範囲:
Value
$12.72
$32.10

Immunovant Inc Stock (IMVT) Company Profile

Name
名前
Immunovant Inc
Name
セクター
Healthcare (1143)
Name
電話
917-580-3099
Name
住所
320 WEST 37TH STREET, NEW YORK, NY
Name
職員
362
Name
Twitter
Name
次回の収益日
2025-08-08
Name
最新のSEC提出書
Name
IMVT's Discussions on Twitter

IMVT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
IMVT
Immunovant Inc
15.67 2.69B 0 -382.71M -325.64M -2.62
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
381.87 96.56B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
449.58 60.08B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
555.51 61.15B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
711.09 44.66B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
328.71 36.23B 3.81B -644.79M -669.77M -6.24

Immunovant Inc Stock (IMVT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-10 再開されました Goldman Neutral
2025-03-03 開始されました Jefferies Hold
2025-01-03 ダウングレード Wolfe Research Outperform → Peer Perform
2024-10-10 再開されました Raymond James Outperform
2024-10-09 繰り返されました Oppenheimer Outperform
2024-03-28 開始されました Oppenheimer Outperform
2024-03-13 開始されました Goldman Buy
2024-02-20 開始されました JP Morgan Overweight
2024-02-15 開始されました Wolfe Research Outperform
2023-12-12 開始されました Deutsche Bank Buy
2023-10-13 アップグレード UBS Neutral → Buy
2023-09-26 アップグレード Raymond James Mkt Perform → Outperform
2023-05-01 開始されました BofA Securities Buy
2023-04-25 開始されました Citigroup Buy
2023-03-31 開始されました Piper Sandler Overweight
2023-03-30 開始されました Stifel Buy
2023-02-15 開始されました Cantor Fitzgerald Overweight
2023-02-13 アップグレード Guggenheim Neutral → Buy
2023-01-03 アップグレード Wells Fargo Equal Weight → Overweight
2022-09-26 ダウングレード UBS Buy → Neutral
2021-12-08 開始されました Wells Fargo Equal Weight
2021-08-03 ダウングレード Robert W. Baird Outperform → Neutral
2021-08-02 ダウングレード Credit Suisse Neutral → Underperform
2021-06-01 ダウングレード Guggenheim Buy → Neutral
2021-06-01 ダウングレード Stifel Buy → Hold
2020-10-28 開始されました UBS Buy
2020-10-12 開始されました Guggenheim Buy
2020-10-08 開始されました Stifel Buy
2020-10-02 開始されました Credit Suisse Outperform
2020-08-26 繰り返されました H.C. Wainwright Buy
2020-08-25 開始されました Raymond James Outperform
2020-07-29 開始されました H.C. Wainwright Buy
2020-02-24 開始されました SVB Leerink Outperform
すべてを表示

Immunovant Inc (IMVT) 最新ニュース

pulisher
Sep 23, 2025

Immunovant, Inc. (NASDAQ:IMVT) Receives $33.60 Consensus PT from Analysts - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

Insider Sale: President & Immunovant CEO of $ROIV Sells 683,818 Shares - Quiver Quantitative

Sep 23, 2025
pulisher
Sep 21, 2025

Aug Spikes: Is Immunovant Inc. a play on infrastructure spendingEarnings Recap Summary & Precise Buy Zone Tips - خودرو بانک

Sep 21, 2025
pulisher
Sep 20, 2025

FOMO Trade: What are Immunovant Incs earnings expectations2025 Bull vs Bear & Fast Gaining Stock Strategy Reports - khodrobank.com

Sep 20, 2025
pulisher
Sep 19, 2025

Gap Down: Should value investors consider Immunovant IncJuly 2025 Highlights & Safe Entry Point Identification - خودرو بانک

Sep 19, 2025
pulisher
Sep 18, 2025

Published on: 2025-09-19 07:03:28 - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

Trading Recap: Why is WANG LEE GROUP Inc stock going down2025 Fundamental Recap & Accurate Technical Buy Alerts - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

Sentiment Watch: What are analysts price targets for Immunovant IncJuly 2025 Gainers & Free Expert Approved Momentum Trade Ideas - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

Highs Report: How is Hoth Therapeutics Inc. managing supply chain issues2025 Market Trends & Daily Volume Surge Signals - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

IMMUNOVANT INVESTIGATION INITIATED BY FORMER LOUISIANA - GlobeNewswire

Sep 18, 2025
pulisher
Sep 18, 2025

Published on: 2025-09-18 21:39:43 - خودرو بانک

Sep 18, 2025
pulisher
Sep 17, 2025

Aug Outlook: Does Immunovant Inc. have pricing powerWeekly Stock Summary & Real-Time Market Sentiment Reports - خودرو بانک

Sep 17, 2025
pulisher
Sep 17, 2025

CENTURY ALUMINUM INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Century Aluminum Co. - GlobeNewswire Inc.

Sep 17, 2025
pulisher
Sep 17, 2025

Dow Update: What is Immunovant Inc.’s book value per share2025 Stock Rankings & Fast Entry High Yield Stock Tips - خودرو بانک

Sep 17, 2025
pulisher
Sep 17, 2025

Investment Recap: What dividend growth rate does Immunovant Inc offer2025 Market WrapUp & Weekly High Return Forecasts - khodrobank.com

Sep 17, 2025
pulisher
Sep 17, 2025

Earnings Update: Will Immunovant Inc. benefit from geopolitical trendsTrade Risk Assessment & Capital Efficiency Focused Strategies - خودرو بانک

Sep 17, 2025
pulisher
Sep 16, 2025

Rate Cut: Will Immunovant Inc. benefit from geopolitical trends2025 Technical Patterns & Daily Growth Stock Tips - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Earnings Update: What drives Immunovant Incs stock priceJuly 2025 Movers & Low Risk High Reward Trade Ideas - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Buyback Watch: Will Immunovant Inc announce a stock splitMarket Activity Report & AI Enhanced Trade Execution Alerts - khodrobank.com

Sep 16, 2025
pulisher
Sep 15, 2025

Surprises Report: Is Immunovant Inc affected by consumer sentiment2025 Key Lessons & High Accuracy Trade Signal Alerts - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Profit Recap: Can Monro Inc. weather a recessionWeekly Market Report & Stepwise Swing Trade Plans - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Immunovant, Inc. $IMVT Shares Bought by Woodline Partners LP - MarketBeat

Sep 15, 2025
pulisher
Sep 14, 2025

Insiders At Immunovant Sold US$3.9m In Stock, Alluding To Potential Weakness - 富途牛牛

Sep 14, 2025
pulisher
Sep 14, 2025

Adage Capital Partners GP L.L.C. Has $362,000 Position in Immunovant, Inc. $IMVT - MarketBeat

Sep 14, 2025
pulisher
Sep 13, 2025

Immunovant Inc. stock prediction for this weekJuly 2025 Fed Impact & High Yield Stock Recommendations - newser.com

Sep 13, 2025
pulisher
Sep 13, 2025

Technical analysis overview for Immunovant Inc. stock2025 Breakouts & Breakdowns & Free Reliable Trade Execution Plans - newser.com

Sep 13, 2025
pulisher
Sep 13, 2025

Applying sector rotation models to Immunovant Inc.2025 Technical Patterns & Free Fast Entry Momentum Trade Alerts - newser.com

Sep 13, 2025
pulisher
Sep 13, 2025

Order flow analysis tools used on Immunovant Inc.Weekly Trend Recap & Fast Entry Momentum Alerts - newser.com

Sep 13, 2025
pulisher
Sep 13, 2025

Why Immunovant Stock Blasted Higher Today - MSN

Sep 13, 2025
pulisher
Sep 12, 2025

Immunovant, Inc. $IMVT is Two Seas Capital LP's 10th Largest Position - MarketBeat

Sep 12, 2025
pulisher
Sep 12, 2025

IMMUNOVANT INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Immunovant, Inc.IMVT - Business Wire

Sep 12, 2025
pulisher
Sep 12, 2025

Cubist Systematic Strategies LLC Purchases 47,322 Shares of Immunovant, Inc. $IMVT - MarketBeat

Sep 12, 2025
pulisher
Sep 11, 2025

Roivant Sciences (ROIV) Is Up 9.4% After Positive Immunovant Data and Japan Orphan Drug NodWhat's Changed - Yahoo Finance

Sep 11, 2025
pulisher
Sep 11, 2025

EFG Asset Management North America Corp. Has $2.23 Million Stock Holdings in Immunovant, Inc. $IMVT - MarketBeat

Sep 11, 2025
pulisher
Sep 10, 2025

Immunovant (IMVT) Up 7.8% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Sep 10, 2025
pulisher
Sep 10, 2025

Immunovant (IMVT) Highlights New Graves’ Disease Data Can Its Pipeline Deliver Sustainable Innovation? - Yahoo Finance

Sep 10, 2025
pulisher
Sep 09, 2025

What data driven models say about Immunovant Inc.’s futureWall Street Watch & Low Drawdown Trading Strategies - Newser

Sep 09, 2025
pulisher
Sep 09, 2025

Canada Pension Plan Investment Board Has $3.12 Million Position in Immunovant, Inc. $IMVT - MarketBeat

Sep 09, 2025
pulisher
Sep 09, 2025

A Look at Immunovant's Valuation Following New Batoclimab Data Update for Graves' Disease - Yahoo Finance

Sep 09, 2025
pulisher
Sep 09, 2025

Immunovant's (IMVT) "Buy" Rating Reiterated at HC Wainwright - MarketBeat

Sep 09, 2025
pulisher
Sep 08, 2025

Immunovant, Inc. $IMVT Shares Acquired by Granahan Investment Management LLC - MarketBeat

Sep 08, 2025
pulisher
Sep 08, 2025

Regression Model Predicts Rangebound Movement in Immunovant Inc.July 2025 News Drivers & Weekly Watchlist of Top Performers - beatles.ru

Sep 08, 2025
pulisher
Sep 08, 2025

Immunovant Inc. Pullback Analyzed — Is It Time to Exit2025 EndofYear Setup & High Return Trade Opportunity Guides - beatles.ru

Sep 08, 2025
pulisher
Sep 08, 2025

Immunovant (NASDAQ:IMVT) Shares Up 10%What's Next? - MarketBeat

Sep 08, 2025
pulisher
Sep 07, 2025

LifeSci Capital Maintains a Buy on Immunovant (IMVT) With a $50 PT - MSN

Sep 07, 2025
pulisher
Sep 07, 2025

Should you avoid Immunovant Inc. stock right nowJuly 2025 Selloffs & Daily Chart Pattern Signals - beatles.ru

Sep 07, 2025
pulisher
Sep 07, 2025

Is Immunovant Inc. stock a good pick for beginners2025 Bull vs Bear & Real-Time Price Movement Reports - 뉴스영

Sep 07, 2025
pulisher
Sep 07, 2025

Immunovant, Inc. $IMVT Shares Bought by ADAR1 Capital Management LLC - MarketBeat

Sep 07, 2025
pulisher
Sep 06, 2025

Visual analytics tools that track Immunovant Inc. performanceMarket Risk Report & Short-Term High Return Ideas - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Immunovant, Inc. $IMVT Holdings Lowered by Redmile Group LLC - MarketBeat

Sep 06, 2025
pulisher
Sep 06, 2025

OMERS ADMINISTRATION Corp Takes $825,000 Position in Immunovant, Inc. $IMVT - MarketBeat

Sep 06, 2025

Immunovant Inc (IMVT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Immunovant Inc (IMVT) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Geffner Michael
Chief Medical Officer
Jul 23 '25
Sale
18.15
2,385
43,288
221,825
Geffner Michael
Chief Medical Officer
Jul 09 '25
Sale
17.24
1,160
19,998
224,210
Stout Jay S
Chief Technology Officer
Jul 09 '25
Sale
17.24
1,519
26,188
207,724
$34.90
price down icon 2.43%
$81.66
price down icon 2.97%
$28.84
price down icon 2.07%
$98.08
price down icon 1.67%
$135.59
price down icon 3.84%
biotechnology ONC
$328.71
price down icon 0.34%
大文字化:     |  ボリューム (24 時間):